(MedPage Today) — A randomized trial laid the groundwork for FFRangio, a proprietary angiography-derived fractional flow reserve (FFR) tool, as a potential gatekeeper for coronary revascularization.
When put to the test in the PROVISION trial…
Source link : https://www.medpagetoday.com/meetingcoverage/europcr/115752
Author :
Publish date : 2025-05-23 18:15:00
Copyright for syndicated content belongs to the linked Source.
